nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—type 2 diabetes mellitus	0.171	0.614	CbGaD
Methazolamide—CYP3A4—type 2 diabetes mellitus	0.107	0.386	CbGaD
Methazolamide—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0299	0.0622	CbGbCtD
Methazolamide—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0266	0.0554	CbGbCtD
Methazolamide—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0226	0.0471	CbGbCtD
Methazolamide—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0194	0.0404	CbGbCtD
Methazolamide—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.019	0.0395	CbGbCtD
Methazolamide—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0173	0.0361	CbGbCtD
Methazolamide—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0165	0.0343	CbGbCtD
Methazolamide—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0165	0.0343	CbGbCtD
Methazolamide—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0161	0.0336	CbGbCtD
Methazolamide—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0153	0.0318	CbGbCtD
Methazolamide—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0152	0.0317	CbGbCtD
Methazolamide—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0147	0.0306	CbGbCtD
Methazolamide—SLC22A6—Losartan—type 2 diabetes mellitus	0.014	0.0291	CbGbCtD
Methazolamide—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0137	0.0285	CbGbCtD
Methazolamide—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0137	0.0285	CbGbCtD
Methazolamide—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0126	0.0263	CbGbCtD
Methazolamide—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0125	0.0261	CbGbCtD
Methazolamide—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0124	0.0258	CbGbCtD
Methazolamide—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0122	0.0254	CbGbCtD
Methazolamide—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0116	0.0241	CbGbCtD
Methazolamide—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0112	0.0233	CbGbCtD
Methazolamide—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.011	0.023	CbGbCtD
Methazolamide—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0104	0.0216	CbGbCtD
Methazolamide—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0101	0.021	CbGbCtD
Methazolamide—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00996	0.0207	CbGbCtD
Methazolamide—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0095	0.0198	CbGbCtD
Methazolamide—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00911	0.019	CbGbCtD
Methazolamide—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00881	0.0184	CbGbCtD
Methazolamide—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00844	0.0176	CbGbCtD
Methazolamide—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00797	0.0166	CbGbCtD
Methazolamide—CYP2C19—Losartan—type 2 diabetes mellitus	0.00772	0.0161	CbGbCtD
Methazolamide—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00702	0.0146	CbGbCtD
Methazolamide—CYP2C9—Losartan—type 2 diabetes mellitus	0.00642	0.0134	CbGbCtD
Methazolamide—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00604	0.0126	CbGbCtD
Methazolamide—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00579	0.0121	CbGbCtD
Methazolamide—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00579	0.0121	CbGbCtD
Methazolamide—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00548	0.0114	CbGbCtD
Methazolamide—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00408	0.0085	CbGbCtD
Methazolamide—CYP3A4—Losartan—type 2 diabetes mellitus	0.00373	0.00777	CbGbCtD
Methazolamide—CA1—nerve—type 2 diabetes mellitus	0.00125	0.0716	CbGeAlD
Methazolamide—CA9—islet of Langerhans—type 2 diabetes mellitus	0.00103	0.0592	CbGeAlD
Methazolamide—CA4—nerve—type 2 diabetes mellitus	0.000978	0.056	CbGeAlD
Methazolamide—CA7—kidney—type 2 diabetes mellitus	0.000833	0.0477	CbGeAlD
Methazolamide—CA5A—liver—type 2 diabetes mellitus	0.000792	0.0453	CbGeAlD
Methazolamide—Acetazolamide—CYP3A4—type 2 diabetes mellitus	0.000778	1	CrCbGaD
Methazolamide—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.000688	0.0393	CbGeAlD
Methazolamide—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000588	0.0337	CbGeAlD
Methazolamide—CA12—kidney—type 2 diabetes mellitus	0.000541	0.031	CbGeAlD
Methazolamide—CA5B—cardiovascular system—type 2 diabetes mellitus	0.000496	0.0284	CbGeAlD
Methazolamide—CA5B—pancreas—type 2 diabetes mellitus	0.000482	0.0276	CbGeAlD
Methazolamide—CA4—islet of Langerhans—type 2 diabetes mellitus	0.000474	0.0271	CbGeAlD
Methazolamide—CA14—liver—type 2 diabetes mellitus	0.000439	0.0251	CbGeAlD
Methazolamide—CA1—cardiovascular system—type 2 diabetes mellitus	0.000438	0.0251	CbGeAlD
Methazolamide—CA5B—adipose tissue—type 2 diabetes mellitus	0.000438	0.025	CbGeAlD
Methazolamide—CA1—kidney—type 2 diabetes mellitus	0.000429	0.0245	CbGeAlD
Methazolamide—CA1—pancreas—type 2 diabetes mellitus	0.000426	0.0244	CbGeAlD
Methazolamide—CA2—islet of Langerhans—type 2 diabetes mellitus	0.000393	0.0225	CbGeAlD
Methazolamide—CA1—adipose tissue—type 2 diabetes mellitus	0.000386	0.0221	CbGeAlD
Methazolamide—CA4—nephron tubule—type 2 diabetes mellitus	0.000381	0.0218	CbGeAlD
Methazolamide—CA4—cardiovascular system—type 2 diabetes mellitus	0.000343	0.0196	CbGeAlD
Methazolamide—CA2—retina—type 2 diabetes mellitus	0.000336	0.0192	CbGeAlD
Methazolamide—CA4—kidney—type 2 diabetes mellitus	0.000335	0.0192	CbGeAlD
Methazolamide—CA4—cortex of kidney—type 2 diabetes mellitus	0.000326	0.0187	CbGeAlD
Methazolamide—CA2—nephron tubule—type 2 diabetes mellitus	0.000316	0.0181	CbGeAlD
Methazolamide—CA4—adipose tissue—type 2 diabetes mellitus	0.000302	0.0173	CbGeAlD
Methazolamide—CA2—cardiovascular system—type 2 diabetes mellitus	0.000284	0.0163	CbGeAlD
Methazolamide—CA2—kidney—type 2 diabetes mellitus	0.000278	0.0159	CbGeAlD
Methazolamide—CA2—pancreas—type 2 diabetes mellitus	0.000276	0.0158	CbGeAlD
Methazolamide—CA1—liver—type 2 diabetes mellitus	0.000271	0.0155	CbGeAlD
Methazolamide—CA2—cortex of kidney—type 2 diabetes mellitus	0.000271	0.0155	CbGeAlD
Methazolamide—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000254	0.0145	CbGeAlD
Methazolamide—CA2—adipose tissue—type 2 diabetes mellitus	0.00025	0.0143	CbGeAlD
Methazolamide—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000244	0.00162	CcSEcCtD
Methazolamide—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00162	CcSEcCtD
Methazolamide—Convulsion—Glyburide—type 2 diabetes mellitus	0.000244	0.00162	CcSEcCtD
Methazolamide—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000242	0.0016	CcSEcCtD
Methazolamide—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000241	0.0016	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Ramipril—type 2 diabetes mellitus	0.000241	0.0016	CcSEcCtD
Methazolamide—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.00024	0.0138	CbGeAlD
Methazolamide—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.00024	0.00159	CcSEcCtD
Methazolamide—Fatigue—Glimepiride—type 2 diabetes mellitus	0.00024	0.00159	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.00024	0.00159	CcSEcCtD
Methazolamide—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000239	0.00159	CcSEcCtD
Methazolamide—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00159	CcSEcCtD
Methazolamide—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000238	0.00158	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000238	0.00158	CcSEcCtD
Methazolamide—Urticaria—Glipizide—type 2 diabetes mellitus	0.000237	0.00157	CcSEcCtD
Methazolamide—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000235	0.00156	CcSEcCtD
Methazolamide—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000234	0.00155	CcSEcCtD
Methazolamide—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000233	0.00155	CcSEcCtD
Methazolamide—Confusional state—Glyburide—type 2 diabetes mellitus	0.000231	0.00153	CcSEcCtD
Methazolamide—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000229	0.00152	CcSEcCtD
Methazolamide—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000229	0.00152	CcSEcCtD
Methazolamide—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00152	CcSEcCtD
Methazolamide—Malaise—Gliclazide—type 2 diabetes mellitus	0.000228	0.00151	CcSEcCtD
Methazolamide—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000228	0.013	CbGeAlD
Methazolamide—Rash—Repaglinide—type 2 diabetes mellitus	0.000227	0.00151	CcSEcCtD
Methazolamide—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000227	0.00151	CcSEcCtD
Methazolamide—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000227	0.00151	CcSEcCtD
Methazolamide—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000227	0.00151	CcSEcCtD
Methazolamide—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000226	0.0015	CcSEcCtD
Methazolamide—Headache—Repaglinide—type 2 diabetes mellitus	0.000226	0.0015	CcSEcCtD
Methazolamide—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00149	CcSEcCtD
Methazolamide—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000225	0.00149	CcSEcCtD
Methazolamide—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000224	0.00149	CcSEcCtD
Methazolamide—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00148	CcSEcCtD
Methazolamide—CYP2E1—kidney—type 2 diabetes mellitus	0.000223	0.0128	CbGeAlD
Methazolamide—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000221	0.00147	CcSEcCtD
Methazolamide—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000221	0.00147	CcSEcCtD
Methazolamide—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00022	0.00146	CcSEcCtD
Methazolamide—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000219	0.00145	CcSEcCtD
Methazolamide—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000219	0.00145	CcSEcCtD
Methazolamide—Anorexia—Glyburide—type 2 diabetes mellitus	0.000219	0.00145	CcSEcCtD
Methazolamide—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00145	CcSEcCtD
Methazolamide—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000217	0.0124	CbGeAlD
Methazolamide—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000217	0.00144	CcSEcCtD
Methazolamide—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00144	CcSEcCtD
Methazolamide—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Methazolamide—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00142	CcSEcCtD
Methazolamide—Nausea—Repaglinide—type 2 diabetes mellitus	0.000214	0.00142	CcSEcCtD
Methazolamide—Asthenia—Glipizide—type 2 diabetes mellitus	0.000214	0.00142	CcSEcCtD
Methazolamide—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000214	0.00142	CcSEcCtD
Methazolamide—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000213	0.00142	CcSEcCtD
Methazolamide—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000213	0.00141	CcSEcCtD
Methazolamide—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000212	0.00141	CcSEcCtD
Methazolamide—Photosensitivity reaction—Ramipril—type 2 diabetes mellitus	0.000211	0.0014	CcSEcCtD
Methazolamide—Vertigo—Valsartan—type 2 diabetes mellitus	0.000208	0.00138	CcSEcCtD
Methazolamide—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000208	0.00138	CcSEcCtD
Methazolamide—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000207	0.00137	CcSEcCtD
Methazolamide—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00137	CcSEcCtD
Methazolamide—Malaise—Orlistat—type 2 diabetes mellitus	0.000207	0.00137	CcSEcCtD
Methazolamide—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000206	0.00137	CcSEcCtD
Methazolamide—Vertigo—Orlistat—type 2 diabetes mellitus	0.000206	0.00137	CcSEcCtD
Methazolamide—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000205	0.00136	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Methazolamide—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Methazolamide—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Methazolamide—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Methazolamide—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Methazolamide—Tinnitus—Losartan—type 2 diabetes mellitus	0.000201	0.00133	CcSEcCtD
Methazolamide—Asthenia—Glimepiride—type 2 diabetes mellitus	0.0002	0.00132	CcSEcCtD
Methazolamide—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.0002	0.00132	CcSEcCtD
Methazolamide—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Methazolamide—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Methazolamide—Convulsion—Orlistat—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Methazolamide—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00132	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Methazolamide—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000196	0.0013	CcSEcCtD
Methazolamide—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000195	0.0013	CcSEcCtD
Methazolamide—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Methazolamide—Discomfort—Orlistat—type 2 diabetes mellitus	0.000193	0.00128	CcSEcCtD
Methazolamide—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000192	0.00127	CcSEcCtD
Methazolamide—CYP2C19—liver—type 2 diabetes mellitus	0.000192	0.011	CbGeAlD
Methazolamide—Malaise—Metformin—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Methazolamide—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Methazolamide—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Methazolamide—Vomiting—Glipizide—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Methazolamide—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000189	0.00126	CcSEcCtD
Methazolamide—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000189	0.00125	CcSEcCtD
Methazolamide—Rash—Glipizide—type 2 diabetes mellitus	0.000188	0.00125	CcSEcCtD
Methazolamide—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000188	0.00125	CcSEcCtD
Methazolamide—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000187	0.00124	CcSEcCtD
Methazolamide—Headache—Glipizide—type 2 diabetes mellitus	0.000187	0.00124	CcSEcCtD
Methazolamide—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Methazolamide—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Methazolamide—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Methazolamide—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Methazolamide—Urticaria—Glyburide—type 2 diabetes mellitus	0.000182	0.00121	CcSEcCtD
Methazolamide—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Methazolamide—Anorexia—Valsartan—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Methazolamide—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Methazolamide—Malaise—Irbesartan—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Methazolamide—CYP3A4—kidney—type 2 diabetes mellitus	0.000179	0.0103	CbGeAlD
Methazolamide—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Methazolamide—Headache—Pioglitazone—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Methazolamide—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000178	0.00118	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000178	0.00118	CcSEcCtD
Methazolamide—Discomfort—Metformin—type 2 diabetes mellitus	0.000178	0.00118	CcSEcCtD
Methazolamide—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000178	0.00118	CcSEcCtD
Methazolamide—Nausea—Glipizide—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Methazolamide—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Methazolamide—CYP2D6—kidney—type 2 diabetes mellitus	0.000176	0.0101	CbGeAlD
Methazolamide—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000176	0.00117	CcSEcCtD
Methazolamide—CA2—liver—type 2 diabetes mellitus	0.000176	0.0101	CbGeAlD
Methazolamide—Rash—Glimepiride—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Methazolamide—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Methazolamide—Rash—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Methazolamide—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Methazolamide—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000175	0.00116	CcSEcCtD
Methazolamide—Headache—Glimepiride—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Methazolamide—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Methazolamide—Headache—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Methazolamide—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Methazolamide—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Methazolamide—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Methazolamide—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Methazolamide—Malaise—Losartan—type 2 diabetes mellitus	0.000169	0.00112	CcSEcCtD
Methazolamide—Vertigo—Losartan—type 2 diabetes mellitus	0.000169	0.00112	CcSEcCtD
Methazolamide—Somnolence—Valsartan—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Methazolamide—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Methazolamide—Leukopenia—Losartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Methazolamide—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Methazolamide—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Methazolamide—Nausea—Glimepiride—type 2 diabetes mellitus	0.000165	0.0011	CcSEcCtD
Methazolamide—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Methazolamide—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Methazolamide—Asthenia—Glyburide—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Methazolamide—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Methazolamide—Anorexia—Metformin—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Methazolamide—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Methazolamide—Fatigue—Valsartan—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Methazolamide—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Methazolamide—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Methazolamide—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Methazolamide—Fatigue—Orlistat—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Methazolamide—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00106	CcSEcCtD
Methazolamide—Rash—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Methazolamide—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Methazolamide—Discomfort—Losartan—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Methazolamide—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000158	0.00104	CcSEcCtD
Methazolamide—Headache—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Methazolamide—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Methazolamide—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000155	0.00103	CcSEcCtD
Methazolamide—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000155	0.00103	CcSEcCtD
Methazolamide—Confusional state—Losartan—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Methazolamide—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Methazolamide—Somnolence—Metformin—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Methazolamide—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Methazolamide—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000152	0.00101	CcSEcCtD
Methazolamide—Urticaria—Valsartan—type 2 diabetes mellitus	0.00015	0.000997	CcSEcCtD
Methazolamide—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00015	0.000994	CcSEcCtD
Methazolamide—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000149	0.00099	CcSEcCtD
Methazolamide—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000149	0.000989	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000149	0.000987	CcSEcCtD
Methazolamide—Fatigue—Metformin—type 2 diabetes mellitus	0.000149	0.000986	CcSEcCtD
Methazolamide—Urticaria—Orlistat—type 2 diabetes mellitus	0.000149	0.000986	CcSEcCtD
Methazolamide—CYP2C9—liver—type 2 diabetes mellitus	0.000149	0.0085	CbGeAlD
Methazolamide—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000148	0.000981	CcSEcCtD
Methazolamide—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000148	0.00098	CcSEcCtD
Methazolamide—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000146	0.000969	CcSEcCtD
Methazolamide—Anorexia—Losartan—type 2 diabetes mellitus	0.000146	0.000968	CcSEcCtD
Methazolamide—Vomiting—Glyburide—type 2 diabetes mellitus	0.000146	0.000968	CcSEcCtD
Methazolamide—Malaise—Ramipril—type 2 diabetes mellitus	0.000145	0.000962	CcSEcCtD
Methazolamide—Rash—Glyburide—type 2 diabetes mellitus	0.000145	0.00096	CcSEcCtD
Methazolamide—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000145	0.000959	CcSEcCtD
Methazolamide—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000145	0.000959	CcSEcCtD
Methazolamide—Vertigo—Ramipril—type 2 diabetes mellitus	0.000145	0.000959	CcSEcCtD
Methazolamide—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000144	0.000955	CcSEcCtD
Methazolamide—Headache—Glyburide—type 2 diabetes mellitus	0.000144	0.000953	CcSEcCtD
Methazolamide—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000143	0.00095	CcSEcCtD
Methazolamide—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000142	0.000942	CcSEcCtD
Methazolamide—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000141	0.000938	CcSEcCtD
Methazolamide—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000141	0.000935	CcSEcCtD
Methazolamide—CYP2E1—liver—type 2 diabetes mellitus	0.000141	0.00806	CbGeAlD
Methazolamide—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.00014	0.000932	CcSEcCtD
Methazolamide—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00014	0.00093	CcSEcCtD
Methazolamide—Convulsion—Ramipril—type 2 diabetes mellitus	0.000139	0.000924	CcSEcCtD
Methazolamide—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000138	0.000912	CcSEcCtD
Methazolamide—Urticaria—Metformin—type 2 diabetes mellitus	0.000137	0.000908	CcSEcCtD
Methazolamide—Nausea—Glyburide—type 2 diabetes mellitus	0.000136	0.000904	CcSEcCtD
Methazolamide—Somnolence—Losartan—type 2 diabetes mellitus	0.000136	0.000903	CcSEcCtD
Methazolamide—Asthenia—Valsartan—type 2 diabetes mellitus	0.000136	0.000901	CcSEcCtD
Methazolamide—Discomfort—Ramipril—type 2 diabetes mellitus	0.000135	0.000897	CcSEcCtD
Methazolamide—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000135	0.000894	CcSEcCtD
Methazolamide—Asthenia—Orlistat—type 2 diabetes mellitus	0.000134	0.00089	CcSEcCtD
Methazolamide—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000134	0.000889	CcSEcCtD
Methazolamide—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000133	0.000883	CcSEcCtD
Methazolamide—Confusional state—Ramipril—type 2 diabetes mellitus	0.000132	0.000878	CcSEcCtD
Methazolamide—Fatigue—Losartan—type 2 diabetes mellitus	0.000132	0.000875	CcSEcCtD
Methazolamide—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000131	0.000871	CcSEcCtD
Methazolamide—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000131	0.000869	CcSEcCtD
Methazolamide—Rash—Gliclazide—type 2 diabetes mellitus	0.00013	0.000862	CcSEcCtD
Methazolamide—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00013	0.000861	CcSEcCtD
Methazolamide—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00013	0.000859	CcSEcCtD
Methazolamide—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000129	0.000857	CcSEcCtD
Methazolamide—Headache—Gliclazide—type 2 diabetes mellitus	0.000129	0.000856	CcSEcCtD
Methazolamide—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000129	0.000853	CcSEcCtD
Methazolamide—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000128	0.000849	CcSEcCtD
Methazolamide—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000126	0.000837	CcSEcCtD
Methazolamide—Anorexia—Ramipril—type 2 diabetes mellitus	0.000125	0.00083	CcSEcCtD
Methazolamide—Asthenia—Metformin—type 2 diabetes mellitus	0.000124	0.00082	CcSEcCtD
Methazolamide—Nausea—Gliclazide—type 2 diabetes mellitus	0.000122	0.000812	CcSEcCtD
Methazolamide—Urticaria—Losartan—type 2 diabetes mellitus	0.000122	0.000807	CcSEcCtD
Methazolamide—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000121	0.000803	CcSEcCtD
Methazolamide—Vomiting—Valsartan—type 2 diabetes mellitus	0.00012	0.000798	CcSEcCtD
Methazolamide—Rash—Valsartan—type 2 diabetes mellitus	0.000119	0.000792	CcSEcCtD
Methazolamide—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000119	0.000791	CcSEcCtD
Methazolamide—Vomiting—Orlistat—type 2 diabetes mellitus	0.000119	0.000789	CcSEcCtD
Methazolamide—Headache—Valsartan—type 2 diabetes mellitus	0.000119	0.000787	CcSEcCtD
Methazolamide—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000118	0.000782	CcSEcCtD
Methazolamide—Rash—Orlistat—type 2 diabetes mellitus	0.000118	0.000782	CcSEcCtD
Methazolamide—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000118	0.000782	CcSEcCtD
Methazolamide—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000118	0.000782	CcSEcCtD
Methazolamide—Headache—Orlistat—type 2 diabetes mellitus	0.000117	0.000777	CcSEcCtD
Methazolamide—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000117	0.000774	CcSEcCtD
Methazolamide—Somnolence—Ramipril—type 2 diabetes mellitus	0.000117	0.000774	CcSEcCtD
Methazolamide—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000116	0.000766	CcSEcCtD
Methazolamide—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000114	0.000757	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000113	0.000752	CcSEcCtD
Methazolamide—CYP3A4—liver—type 2 diabetes mellitus	0.000113	0.00649	CbGeAlD
Methazolamide—Fatigue—Ramipril—type 2 diabetes mellitus	0.000113	0.000751	CcSEcCtD
Methazolamide—Nausea—Valsartan—type 2 diabetes mellitus	0.000112	0.000746	CcSEcCtD
Methazolamide—CYP2D6—liver—type 2 diabetes mellitus	0.000112	0.00638	CbGeAlD
Methazolamide—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000111	0.000738	CcSEcCtD
Methazolamide—Nausea—Orlistat—type 2 diabetes mellitus	0.000111	0.000737	CcSEcCtD
Methazolamide—Asthenia—Losartan—type 2 diabetes mellitus	0.00011	0.000729	CcSEcCtD
Methazolamide—Vomiting—Metformin—type 2 diabetes mellitus	0.00011	0.000727	CcSEcCtD
Methazolamide—Rash—Metformin—type 2 diabetes mellitus	0.000109	0.000721	CcSEcCtD
Methazolamide—Dermatitis—Metformin—type 2 diabetes mellitus	0.000109	0.00072	CcSEcCtD
Methazolamide—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000108	0.000718	CcSEcCtD
Methazolamide—Headache—Metformin—type 2 diabetes mellitus	0.000108	0.000716	CcSEcCtD
Methazolamide—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000105	0.000695	CcSEcCtD
Methazolamide—Urticaria—Ramipril—type 2 diabetes mellitus	0.000104	0.000692	CcSEcCtD
Methazolamide—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000104	0.000688	CcSEcCtD
Methazolamide—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000103	0.000686	CcSEcCtD
Methazolamide—Rash—Irbesartan—type 2 diabetes mellitus	0.000103	0.00068	CcSEcCtD
Methazolamide—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000103	0.00068	CcSEcCtD
Methazolamide—Nausea—Metformin—type 2 diabetes mellitus	0.000102	0.000679	CcSEcCtD
Methazolamide—Headache—Irbesartan—type 2 diabetes mellitus	0.000102	0.000676	CcSEcCtD
Methazolamide—Vomiting—Losartan—type 2 diabetes mellitus	9.74e-05	0.000646	CcSEcCtD
Methazolamide—Nausea—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000641	CcSEcCtD
Methazolamide—Rash—Losartan—type 2 diabetes mellitus	9.66e-05	0.00064	CcSEcCtD
Methazolamide—Dermatitis—Losartan—type 2 diabetes mellitus	9.65e-05	0.00064	CcSEcCtD
Methazolamide—Headache—Losartan—type 2 diabetes mellitus	9.59e-05	0.000636	CcSEcCtD
Methazolamide—Asthenia—Ramipril—type 2 diabetes mellitus	9.42e-05	0.000625	CcSEcCtD
Methazolamide—Nausea—Losartan—type 2 diabetes mellitus	9.1e-05	0.000603	CcSEcCtD
Methazolamide—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000596	CcSEcCtD
Methazolamide—Vomiting—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000554	CcSEcCtD
Methazolamide—Rash—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000549	CcSEcCtD
Methazolamide—Dermatitis—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000548	CcSEcCtD
Methazolamide—Headache—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000545	CcSEcCtD
Methazolamide—Nausea—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000517	CcSEcCtD
Methazolamide—CA7—Metabolism—AKT1—type 2 diabetes mellitus	5.67e-06	7.8e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.66e-06	7.78e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.66e-06	7.78e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	5.64e-06	7.75e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.64e-06	7.75e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.63e-06	7.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.57e-06	7.66e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	5.55e-06	7.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	5.52e-06	7.59e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	5.52e-06	7.59e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.52e-06	7.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	5.5e-06	7.57e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.42e-06	7.45e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GCG—type 2 diabetes mellitus	5.42e-06	7.45e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	5.41e-06	7.44e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.38e-06	7.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	5.38e-06	7.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	5.38e-06	7.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	5.38e-06	7.4e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	5.37e-06	7.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	5.37e-06	7.39e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	5.37e-06	7.39e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	5.35e-06	7.35e-05	CbGpPWpGaD
Methazolamide—CA12—Metabolism—AKT1—type 2 diabetes mellitus	5.25e-06	7.22e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	5.25e-06	7.22e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	5.19e-06	7.14e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	5.18e-06	7.12e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	5.15e-06	7.08e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	5.15e-06	7.08e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	5.14e-06	7.06e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	5.08e-06	6.98e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	5.08e-06	6.98e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.03e-06	6.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.03e-06	6.92e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.98e-06	6.85e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.96e-06	6.82e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.96e-06	6.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.95e-06	6.8e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.95e-06	6.8e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.95e-06	6.8e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	4.94e-06	6.79e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.92e-06	6.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.91e-06	6.75e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	4.91e-06	6.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	4.91e-06	6.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	4.91e-06	6.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	4.88e-06	6.7e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.87e-06	6.7e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.84e-06	6.65e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.83e-06	6.64e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	4.83e-06	6.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	4.83e-06	6.63e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	4.83e-06	6.63e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.79e-06	6.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.79e-06	6.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.79e-06	6.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	4.79e-06	6.58e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.77e-06	6.56e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	4.74e-06	6.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.73e-06	6.51e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.69e-06	6.45e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.67e-06	6.43e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.67e-06	6.43e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.65e-06	6.4e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.63e-06	6.36e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.59e-06	6.31e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.59e-06	6.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.5e-06	6.19e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.46e-06	6.13e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.44e-06	6.1e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.44e-06	6.1e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.44e-06	6.1e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.41e-06	6.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.41e-06	6.07e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.4e-06	6.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.4e-06	6.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.4e-06	6.05e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.36e-06	6e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.36e-06	6e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.36e-06	5.99e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.34e-06	5.96e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.32e-06	5.94e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.32e-06	5.94e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.28e-06	5.88e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.26e-06	5.85e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.26e-06	5.85e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.23e-06	5.82e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.23e-06	5.81e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.22e-06	5.8e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.22e-06	5.8e-05	CbGpPWpGaD
Methazolamide—CA4—Metabolism—AKT1—type 2 diabetes mellitus	4.19e-06	5.76e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.19e-06	5.76e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.18e-06	5.75e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.18e-06	5.75e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.17e-06	5.73e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.15e-06	5.71e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.07e-06	5.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.07e-06	5.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.07e-06	5.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.07e-06	5.6e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.06e-06	5.58e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.04e-06	5.56e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.02e-06	5.53e-05	CbGpPWpGaD
Methazolamide—CA2—Metabolism—AKT1—type 2 diabetes mellitus	4.02e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4.01e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4.01e-06	5.52e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.99e-06	5.49e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.98e-06	5.47e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.98e-06	5.47e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.91e-06	5.38e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.9e-06	5.37e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.88e-06	5.33e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.86e-06	5.31e-05	CbGpPWpGaD
Methazolamide—CA1—Metabolism—AKT1—type 2 diabetes mellitus	3.85e-06	5.29e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.85e-06	5.29e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.85e-06	5.29e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.83e-06	5.27e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.82e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.82e-06	5.24e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.76e-06	5.17e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.64e-06	5e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.63e-06	4.99e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.61e-06	4.96e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.61e-06	4.96e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.59e-06	4.93e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.58e-06	4.92e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.57e-06	4.9e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.54e-06	4.87e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.53e-06	4.85e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.44e-06	4.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.39e-06	4.66e-05	CbGpPWpGaD
Methazolamide—CA9—Metabolism—AKT1—type 2 diabetes mellitus	3.39e-06	4.65e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.35e-06	4.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.32e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.32e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.32e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.32e-06	4.56e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.3e-06	4.54e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.29e-06	4.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.29e-06	4.52e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.28e-06	4.51e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.27e-06	4.5e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.26e-06	4.48e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.26e-06	4.48e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.24e-06	4.45e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.24e-06	4.45e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.24e-06	4.45e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.23e-06	4.44e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.22e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.21e-06	4.42e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.2e-06	4.4e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.16e-06	4.35e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.16e-06	4.34e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.14e-06	4.31e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.12e-06	4.29e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.12e-06	4.29e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.11e-06	4.27e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.08e-06	4.23e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.08e-06	4.23e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.05e-06	4.19e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.05e-06	4.19e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.02e-06	4.15e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.99e-06	4.12e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.96e-06	4.06e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.96e-06	4.06e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.95e-06	4.05e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.93e-06	4.03e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.92e-06	4.01e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.9e-06	3.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.9e-06	3.99e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.9e-06	3.99e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.9e-06	3.99e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.87e-06	3.94e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.85e-06	3.92e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.84e-06	3.91e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.83e-06	3.89e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.82e-06	3.88e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.81e-06	3.86e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.81e-06	3.86e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.79e-06	3.84e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.76e-06	3.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.76e-06	3.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.75e-06	3.78e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.72e-06	3.74e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.72e-06	3.74e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.7e-06	3.71e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.67e-06	3.67e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.67e-06	3.67e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.67e-06	3.67e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.65e-06	3.65e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.64e-06	3.64e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.62e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.62e-06	3.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.58e-06	3.55e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.56e-06	3.52e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.54e-06	3.49e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.53e-06	3.48e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.52e-06	3.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.52e-06	3.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.52e-06	3.46e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.51e-06	3.45e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.5e-06	3.44e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.48e-06	3.41e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	3.36e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.4e-06	3.3e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.35e-06	3.23e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.21e-06	3.03e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.19e-06	3e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.17e-06	2.98e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.17e-06	2.98e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.16e-06	2.97e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.16e-06	2.97e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.16e-06	2.96e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.14e-06	2.95e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.13e-06	2.93e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.07e-06	2.84e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.06e-06	2.83e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.06e-06	2.83e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.01e-06	2.76e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	2.73e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.97e-06	2.71e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.97e-06	2.7e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.93e-06	2.66e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.93e-06	2.65e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.9e-06	2.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.9e-06	2.61e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.89e-06	2.59e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.88e-06	2.58e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.88e-06	2.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.88e-06	2.58e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.85e-06	2.55e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.78e-06	2.44e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-06	2.4e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.73e-06	2.38e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.72e-06	2.36e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.69e-06	2.32e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	2.28e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.66e-06	2.27e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.64e-06	2.25e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	1.98e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	1.94e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.3e-06	1.78e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	1.7e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.7e-05	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.69e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	1.56e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.48e-07	1.3e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.72e-07	1.2e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.64e-07	1.19e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.7e-07	7.83e-06	CbGpPWpGaD
